128 related articles for article (PubMed ID: 35480921)
21. Synthesis, Biological Evaluation, and Computer-Aided Drug Designing of New Derivatives of Hyperactive Suberoylanilide Hydroxamic Acid Histone Deacetylase Inhibitors.
Zhang S; Huang W; Li X; Yang Z; Feng B
Chem Biol Drug Des; 2015 Oct; 86(4):795-804. PubMed ID: 25763653
[TBL] [Abstract][Full Text] [Related]
22. Anti-Melanoma Activities of Artemisone and Prenylated Amino-Artemisinins in Combination With Known Anticancer Drugs.
Wong HN; Lewies A; Haigh M; Viljoen JM; Wentzel JF; Haynes RK; du Plessis LH
Front Pharmacol; 2020; 11():558894. PubMed ID: 33117161
[TBL] [Abstract][Full Text] [Related]
23. The Artemiside-Artemisox-Artemisone-M1 Tetrad: Efficacies against Blood Stage
Gibhard L; Coertzen D; Reader J; van der Watt ME; Birkholtz LM; Wong HN; Batty KT; Haynes RK; Wiesner L
Pharmaceutics; 2021 Dec; 13(12):. PubMed ID: 34959347
[TBL] [Abstract][Full Text] [Related]
24. Enhancement of vincristine cytotoxicity in drug-resistant cells by simultaneous treatment with onconase, an antitumor ribonuclease.
Rybak SM; Pearson JW; Fogler WE; Volker K; Spence SE; Newton DL; Mikulski SM; Ardelt W; Riggs CW; Kung HF; Longo DL
J Natl Cancer Inst; 1996 Jun; 88(11):747-53. PubMed ID: 8637029
[TBL] [Abstract][Full Text] [Related]
25. Design, Synthesis and Cytotoxicity of Novel Dihydroartemisinin-Coumarin Hybrids via Click Chemistry.
Tian Y; Liang Z; Xu H; Mou Y; Guo C
Molecules; 2016 Jun; 21(6):. PubMed ID: 27294901
[TBL] [Abstract][Full Text] [Related]
26. Strong effect of copper(II) coordination on antiproliferative activity of thiosemicarbazone-piperazine and thiosemicarbazone-morpholine hybrids.
Bacher F; Dömötör O; Chugunova A; Nagy NV; Filipović L; Radulović S; Enyedy ÉA; Arion VB
Dalton Trans; 2015 May; 44(19):9071-90. PubMed ID: 25896351
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and biological evaluation of novel isoxazole-piperazine hybrids as potential anti-cancer agents with inhibitory effect on liver cancer stem cells.
İbiş K; Nalbat E; Çalışkan B; Kahraman DC; Cetin-Atalay R; Banoglu E
Eur J Med Chem; 2021 Oct; 221():113489. PubMed ID: 33951549
[TBL] [Abstract][Full Text] [Related]
28. [Effect of dihydroartemisinin on multidrug resistance of human oral squamous cell carcinoma cell line KBV200 by regulating ROS-MAPK pathway].
Liu ZZ; Zhao YX; Lin JN; Zhou GP
Shanghai Kou Qiang Yi Xue; 2019 Dec; 28(6):586-590. PubMed ID: 32346700
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and cytotoxicity of novel 10-substituted dihydroartemisinin derivatives containing N-arylphenyl-ethenesulfonamide groups.
Liu Y; Liu Z; Shi J; Chen H; Mi B; Li P; Gong P
Molecules; 2013 Mar; 18(3):2864-77. PubMed ID: 23459298
[TBL] [Abstract][Full Text] [Related]
30. Chemotherapy of L1210 leukemia with 5-azacytidine in combination with vincristine, adriamycin, or beta-cytosine arabinoside.
Presant CA; Vietti TJ; Valeriote F; Coulter DM
J Natl Cancer Inst; 1981 Dec; 67(6):1283-8. PubMed ID: 6171666
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis and biological evaluation of novel hydroxamates and 2-aminobenzamides as potent histone deacetylase inhibitors and antitumor agents.
Xie R; Yao Y; Tang P; Chen G; Liu X; Yun F; Cheng C; Wu X; Yuan Q
Eur J Med Chem; 2017 Jul; 134():1-12. PubMed ID: 28391133
[TBL] [Abstract][Full Text] [Related]
32. Novel bis(pyrazole-benzofuran) hybrids possessing piperazine linker: Synthesis of potent bacterial biofilm and MurB inhibitors.
Mekky AEM; Sanad SMH
Bioorg Chem; 2020 Sep; 102():104094. PubMed ID: 32711085
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors.
Abdullaziz MA; Abdel-Mohsen HT; El Kerdawy AM; Ragab FAF; Ali MM; Abu-Bakr SM; Girgis AS; El Diwani HI
Eur J Med Chem; 2017 Aug; 136():315-329. PubMed ID: 28505536
[TBL] [Abstract][Full Text] [Related]
34. Cytosine arabinoside (ara-C) resistance confers cross-resistance or collateral sensitivity to other classes of anti-leukemic drugs.
Martin-Aragon S; Mukherjee SK; Taylor BJ; Ivy SP; Fu CH; Ardi VC; Avramis VI
Anticancer Res; 2000; 20(1A):139-50. PubMed ID: 10769646
[TBL] [Abstract][Full Text] [Related]
35. Reversal of multidrug resistance in human colon cancer cells expressing the human MDR1 gene by liposomes in combination with monoclonal antibody or verapamil.
Sela S; Husain SR; Pearson JW; Longo DL; Rahman A
J Natl Cancer Inst; 1995 Jan; 87(2):123-8. PubMed ID: 7707383
[TBL] [Abstract][Full Text] [Related]
36. Design, Synthesis, Structure-Activity Relationship and Docking Studies of Novel Functionalized Arylvinyl-1,2,4-Trioxanes as Potent Antiplasmodial as well as Anticancer Agents.
Tiwari MK; Coghi P; Agrawal P; Shyamlal BRK; Jun Yang L; Yadav L; Peng Y; Sharma R; Yadav DK; Sahal D; Kam Wai Wong V; Chaudhary S
ChemMedChem; 2020 Jul; 15(13):1216-1228. PubMed ID: 32392362
[TBL] [Abstract][Full Text] [Related]
37. Novel halogenated arylvinyl-1,2,4 trioxanes as potent antiplasmodial as well as anticancer agents: Synthesis, bioevaluation, structure-activity relationship and in-silico studies.
Tiwari MK; Coghi P; Agrawal P; Yadav DK; Yang LJ; Congling Q; Sahal D; Wai Wong VK; Chaudhary S
Eur J Med Chem; 2021 Nov; 224():113685. PubMed ID: 34303874
[TBL] [Abstract][Full Text] [Related]
38. Moxifloxacin-isatin Hybrids Tethered by 1,2,3-triazole and their Anticancer Activities.
Yang M; Liu H; Zhang Y; Wang X; Xu Z
Curr Top Med Chem; 2020; 20(16):1461-1467. PubMed ID: 31994464
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis and cytotoxic activities of scopoletin-isoxazole and scopoletin-pyrazole hybrids.
Shi W; Hu J; Bao N; Li D; Chen L; Sun J
Bioorg Med Chem Lett; 2017 Jan; 27(2):147-151. PubMed ID: 27956344
[TBL] [Abstract][Full Text] [Related]
40. Design, Synthesis, In Vitro Anticancer Evaluation and Molecular Modelling Studies of 3,4,5-Trimethoxyphenyl-Based Derivatives as Dual EGFR/HDAC Hybrid Inhibitors.
Ibrahim TS; Malebari AM; Mohamed MFA
Pharmaceuticals (Basel); 2021 Nov; 14(11):. PubMed ID: 34832959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
